MIF and neoplasm: The protumoral effects exerted by MIF were further supported in vivo, where MIF deficiency, or its inhibition with 4-iodo-6-phenylpyrimidine (4-IPP) [24], causes tumor-associated MΦ to revert towards an M1-like, inflammatory phenotype [18, 25, 26].